Vertex holder plans sale of 1,500 shares

Vertex Pharmaceuticals shareholder Ourania Tatsis filed a Form 144 notice to sell 1,500 shares of Vertex common stock, with an aggregate market value of $749,992.02, through Fidelity Brokerage Services on NASDAQ around February 13, 2026.

Rhea-AI Filing Summary

Vertex Pharmaceuticals shareholder Ourania Tatsis filed a Form 144 notice to sell 1,500 shares of Vertex common stock, with an aggregate market value of $749,992.02, through Fidelity Brokerage Services on NASDAQ around February 13, 2026.

The filing indicates 253,718,831 Vertex common shares outstanding. The 1,500 shares to be sold trace to restricted stock that vested as compensation in February 2021, in lots of 1,448 and 52 shares acquired from the issuer.

Over the past three months, Tatsis has sold additional Vertex common shares, including 4,500 shares on December 3, 2025 for gross proceeds of $2,024,955.40, 4,500 shares on January 7, 2026 for $2,137,455.00, and 466 shares on February 11, 2026 for $214,560.38.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Vertex (VRTX) by Ourania Tatsis disclose?

The Form 144 discloses that shareholder Ourania Tatsis plans to sell 1,500 shares of Vertex common stock. The shares have an aggregate market value of $749,992.02 and are expected to be sold on the NASDAQ through Fidelity Brokerage Services.

How many Vertex (VRTX) shares is the filer planning to sell under this Form 144?

The filer plans to sell 1,500 shares of Vertex common stock. The table lists an aggregate market value of $749,992.02 for this block, with the transaction expected to occur around February 13, 2026 on the NASDAQ exchange.

What prior Vertex (VRTX) stock sales has Ourania Tatsis reported in the last three months?

The filing shows three prior sales: 4,500 shares on December 3, 2025 for $2,024,955.40, 4,500 shares on January 7, 2026 for $2,137,455.00, and 466 shares on February 11, 2026 for $214,560.38 in gross proceeds.

How did Ourania Tatsis acquire the Vertex (VRTX) shares being sold under Form 144?

The shares were acquired through restricted stock vesting from the issuer as compensation. The filing lists vesting on February 10, 2021 for 1,448 shares and on February 17, 2021 for 52 shares, both categorized as compensation.

What does the Form 144 say about Vertex (VRTX) shares outstanding?

The Form 144 lists 253,718,831 shares of Vertex common stock as outstanding. This figure provides context for the size of the planned 1,500-share sale relative to the company’s total common equity base at the time of the filing.

Which broker and exchange are involved in the planned Vertex (VRTX) share sale?

The notice indicates the planned sale will be executed through Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. The NASDAQ exchange is listed as the marketplace where the 1,500 Vertex common shares are expected to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/13/2026 - 02:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001789815
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERTEX PHARMACEUTICALS INC / MA
SEC File Number	000-19319
Address of Issuer	50 NORTHERN AVENUE BOSTON MASSACHUSETTS 02210
Phone	6173416393
Name of Person for Whose Account the Securities are To Be Sold	Tatsis Ourania
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1500	749992.02	253718831	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2021	Restricted Stock Vesting	Issuer			1448	02/10/2021	Compensation
Common	02/17/2021	Restricted Stock Vesting	Issuer			52	02/17/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ourania Tatsis 50 Northern Avenue Boston MA 02210	Common	12/03/2025	4500	2024955.40
Ourania Tatsis 50 Northern Avenue Boston MA 02210	Common	01/07/2026	4500	2137455.00
Ourania Tatsis 50 Northern Avenue Boston MA 02210	Common	02/11/2026	466	214560.38

144: Remarks and Signature

Remarks
Date of Notice	02/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/21/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jessica Spraker, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Ourania Tatsis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)